Florida SB 784: Legislature

Bill Text

784 
Medicaid Coverage of Continuous Glucose Monitors 
2025-12-08T06:36:47Z 
Requiring the Agency for Health Care Administration, within a specified timeframe, to seek federal approval as needed to provide coverage of continuous glucose monitors and related supplies as a durable medical equipment benefit under the Medicaid program; providing for the reimbursement of such equipment, etc. 
Original Filed Version 
2026 
S 
GB 
General Bill 
__ 

 Florida Senate - 2026 SB 784 

 By Senator Harrell 

 31-00389-26 2026784__ 
 1 A bill to be entitled 
 2 An act relating to Medicaid coverage of continuous 
 3 glucose monitors; requiring the Agency for Health Care 
 4 Administration, within a specified timeframe, to seek 
 5 federal approval as needed to provide coverage of 
 6 continuous glucose monitors and related supplies as a 
 7 durable medical equipment benefit under the Medicaid 
 8 program; providing for the reimbursement of such 
 9 equipment; providing construction; requiring the 
 10 agency to implement these changes upon receiving any 
 11 necessary federal approval; providing an effective 
 12 date. 
 13 
 14 Be It Enacted by the Legislature of the State of Florida: 
 15 
 16 Section 1. (1) Within 30 days after this act becomes a 
 17 law, the Agency for Health Care Administration shall seek 
 18 federal approval through a Medicaid waiver or state plan 
 19 amendment as needed to provide coverage of continuous glucose 
 20 monitors and related supplies as a durable medical equipment 
 21 benefit for Medicaid recipients. A licensed durable medical 
 22 equipment provider must be reimbursed for continuous glucose 
 23 monitors and related supplies, provided the claim is submitted 
 24 through the Medicare Healthcare Common Procedure Coding System. 
 25 The agency may not require such provider to use a National Drug 
 26 Code number as part of such claim submission. 
 27 (2) This section does not preclude the agency from 
 28 providing additional coverage of continuous glucose monitors as 
 29 a Medicaid pharmacy benefit. 
 30 (3) The agency shall begin implementation of these changes 
 31 upon receiving any necessary federal approval. 
 32 Section 2. This act shall take effect upon becoming a law.